Sphingosine Kinase 1 Is Overexpressed And Promotes Proliferation In Human Thyroid Cancer

Hongyu Guan,Liehua Liu,Junchao Cai,Juan Liu,Caisheng Ye,Mengfeng Li,Yanbing Li

DOI: https://doi.org/10.1210/me.2011-1048

2011-01-01

Molecular Endocrinology

Abstract:Sphingosine kinase 1 (SphK1), an oncogenic kinase, has been previously found to be elevated in various types of human cancer and play a role in tumor development and progression. Nevertheless, the biological and clinical significance of SphK1 in thyroid cancer is largely unknown. Here, we demonstrate that the expression of SphK1 is generally up-regulated in thyroid cancer and that its expression level is correlated with the degree of thyroid malignancy. Silencing SphK1 by specific RNA interference is able to suppress the proliferation of thyroid cancer cells, and SphK1 expression level is strongly associated with the expression of proliferation cell nuclear antigen in thyroid cancer tissues. Of particular note is that depletion of SphK1 results in dephosphorylation of protein kinase B and glycogen synthase kinase-3 beta and subsequent inactivation of beta-catenin-T-cell factor/lymphoid enhancing factor transcriptional activity. Hence, taken together, our study has identified SphK1 as a proproliferative oncogenic kinase, an Akt/glycogen synthase kinase-3 beta/beta-catenin activator, and probably a biomarker for thyroid cancer as well. (Molecular Endocrinology 25: 1858-1866, 2011)